JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
LKQ Corp
LKQ
$5.7B
| $10.4M | ﹤0.01% |
396,370
+77,154
| +24% | +$2.16M |
2013 Q2
24 quarters
|
|
2002
Five Below
FIVE
$11.8B
| $10.4M | ﹤0.01% |
86,087
-17,060
| -17% | -$2.25M |
2015 Q3
15 quarters
|
|
2003
Atmos Energy
ATO
$26.7B
| $10.4M | ﹤0.01% |
99,169
-52,936
| -35% | -$5.42M |
2013 Q2
24 quarters
|
|
2004
Donaldson
DCI
$10.5B
| $10.4M | ﹤0.01% |
205,523
+58,666
| +40% | +$2.98M |
2013 Q2
24 quarters
|
|
2005
Commercial Metals
CMC
$7.19B
| $10.4M | ﹤0.01% |
589,973
+52,291
| +10% | +$855K |
2013 Q2
24 quarters
|
|
2006
TransAlta
TAC
$4.1B
| $10.4M | ﹤0.01% |
1,700,079
+1,688,328
| +14,368% | +$11.4M |
2014 Q3
19 quarters
|
|
2007
TD Synnex
SNX
$22.3B
| $10.4M | ﹤0.01% |
211,360
+10,692
| +5% | +$531K |
2015 Q3
15 quarters
|
|
|
FOLD
2008
DELISTED
Amicus Therapeutics
FOLD
| $10.3M | ﹤0.01% |
860,619
-23,488
| -3% | -$298K |
2015 Q3
15 quarters
|
|
2009
Casey's General Stores
CASY
$23.2B
| $10.3M | ﹤0.01% |
66,301
-1,052
| -2% | -$144K |
2013 Q2
24 quarters
|
|
2010
iShares MSCI USA Momentum Factor ETF
MTUM
$20.9B
| $10.3M | ﹤0.01% |
87,029
+4,092
| +5% | +$468K |
2015 Q1
17 quarters
|
|
2011
iShare MSCI Eurozone ETF
EZU
$9.43B
| $10.2M | ﹤0.01% |
261,087
-32,756
| -11% | -$1.29M |
2013 Q4
22 quarters
|
|
|
CZR
2012
PUT
DELISTED
Caesars Entertainment Corporation
CZR
| $10.2M | ﹤0.01% |
878,900
+728,900
| +486% | +$6.91M |
2018 Q3
3 quarters
|
|
2013
Jones Lang LaSalle
JLL
$14.1B
| $10.2M | ﹤0.01% |
74,106
-108,694
| -59% | -$15.4M |
2013 Q2
24 quarters
|
|
|
AAN.A
2014
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $10.2M | ﹤0.01% |
167,958
+80,195
| +91% | +$4.89M |
2013 Q2
24 quarters
|
|
2015
Vanguard Morningstar Large-Cap ETF
VV
$55.3B
| $10.2M | ﹤0.01% |
76,261
+916
| +1% | +$121K |
2013 Q2
24 quarters
|
|
2016
PUT
Baxter International
BAX
$12.5B
| $10.2M | ﹤0.01% |
125,000
| – | – |
2018 Q3
3 quarters
|
|
2017
ePlus
PLUS
$2.43B
| $10.2M | ﹤0.01% |
295,866
+45,386
| +18% | +$1.89M |
2016 Q2
12 quarters
|
|
2018
CALL
Emerson Electric
EMR
$91.8B
| $10.2M | ﹤0.01% |
154,000
+90,000
| +141% | +$6.03M |
2018 Q2
4 quarters
|
|
|
2019
PUT
Emerson Electric
EMR
$91.8B
| $10.2M | ﹤0.01% |
154,000
+90,000
| +141% | +$6.03M |
2018 Q2
4 quarters
|
|
2020
PUT
Seagate
STX
$191B
| $10.1M | ﹤0.01% |
+217,000
| New | +$10.1M |
2019 Q2
0 quarters
|
|
2021
Financial Institutions
FISI
$781M
| $10.1M | ﹤0.01% |
354,304
+154
| +0% | +$4.29K |
2013 Q2
24 quarters
|
|
|
RUBY
2022
DELISTED
Rubius Therapeutics, Inc
RUBY
| $10.1M | ﹤0.01% |
677,188
+72,519
| +12% | +$1.17M |
2018 Q3
3 quarters
|
|
2023
SLM Corp
SLM
$4.28B
| $10.1M | ﹤0.01% |
1,067,496
+87,719
| +9% | +$869K |
2013 Q2
24 quarters
|
|
2024
PUT
BioMarin Pharmaceuticals
BMRN
$11.1B
| $10.1M | ﹤0.01% |
+120,000
| New | +$10.3M |
2019 Q2
0 quarters
|
|
2025
Liberty Media Corporation Series A Common Stock
FWONA
$22.1B
| $10.1M | ﹤0.01% |
301,645
+7,130
| +2% | +$249K |
2013 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.